Multi Hanna Kreasindo Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Multi Hanna Kreasindo Tbk. trades at Rp133 (market cap 498.75B, 2.37M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume). The key difference: Multi Hanna Kreasindo Tbk. and Prodia Diagnostic Line Tbk are close in size by market cap, and Prodia Diagnostic Line Tbk is more actively traded (18.86M versus 2.37M). Which is the better fit depends on your goals.
| MHKI | PRDL | |
|---|---|---|
Market Cap | 498.75B | 470.58B |
Volume | 2.37M | 18.86M |
Lot | 23.66K | 188.57K |
Turnover | 315.07M | 4.97B |
Average Price | 133.17 | 263.63 |
Value | 315.07M | 4.97B |
Indicative Equilibrium Price | 133 | 264 |
Indicative Equilibrium Volume | 800 | 3.64K |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Hanna Kreasindo Tbk (Company), was established on September 23, 2004 based on Deed of Notary Drajat Dramaji, S.H., No.165. The company became effective commercially on September 23, 2004. The parent entity of the Company is PT Multi Hanna Sinergitama and the ultimate beneficial owners of the Company are Mr. Shahabuddin and Mr. Alwi.
Read more on MHKI →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →